257 results on '"Egeberg, Alexander"'
Search Results
2. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
3. Elevated plasma levels of calcitonin gene‐related peptide in individuals with rosacea: A cross‐sectional case–control study
4. Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis – results from a large cross-sectional cohort study
5. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
6. Fatigue is associated with disease severity in adult patients with hidradenitis suppurativa
7. Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials
8. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
9. Drug Survival of Biologics in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
10. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
11. Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
12. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
13. Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective
14. Characteristics of Patients With Psoriasis Treated With Various Biologics – A Danish Cohort Study
15. 534 - Incidence of venous thromboembolic events and atherosclerotic cardiovascular disease risk factors in adolescents and adults with atopic dermatitis in Denmark: a population-based cohort study
16. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis – a cross sectional study
17. Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study
18. The agreement between consumer-driven self-assessment of psoriasis severity and physician-assessed severity based on patient-taken photographs is weak: cross-sectional study
19. Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs
20. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT)
21. Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross‐sectional validation and registry‐based study
22. Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study
23. Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry Study
24. A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agents
25. No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study
26. Impact of Previous Alopecia Areata Treatment on Efficacy Responses After 24 and 48 Weeks of Treatment With Ritlecitinib
27. Atopic dermatitis phenotypes based on cluster analysis of the Danish Skin Cohort
28. Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
29. Characteristics and prognosis of first-time hospitalized patients with generalized pustular psoriasis: insights from national databases
30. Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks
31. Prevalence and incidence of patients with generalized pustular psoriasis in Denmark—A nationwide registry‐based study
32. Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial
33. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
34. Disease‐ and treatment‐related expectations, attitudes, and beliefs among adult patients initiating or switching biological therapies for psoriasis
35. Psychiatric co‐morbidity in patients with hidradenitis suppurativa: A cross‐sectional study of clinical characteristics and burden of disease
36. Predicting discontinuation of biologic therapy caused by adverse events in psoriasis patients—A Danish nationwide cohort study
37. Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: A Danish population-based cohort study
38. Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses
39. Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study
40. The association between Staphylococcus aureus colonization on cheek skin at 2 months and subsequent atopic dermatitis in a prospective birth cohort
41. Correlation between DLQI and PASI in patients with psoriasis - a cross-sectional Global Healthcare Study on Psoriasis (GHSP)
42. Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)
43. Predicting psoriatic arthritis in patients with psoriasis – a Swiss registry study
44. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
45. Rosacea and Neurological Comorbidities
46. Rosacea and Gastrointestinal Comorbidities
47. Rosacea and Cancer
48. Rosacea and Cardiovascular Comorbidities
49. Mild-to-moderate severity of psoriasis may be assessed remotely based on photographs and self-reported extent of skin involvement
50. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.